News

TipRanks on MSN5d

AbbVie’s Pediatric Ulcerative Colitis Study: A Potential Game-Changer

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...
TipRanks on MSN6d

AbbVie’s Risankizumab Study: A Potential Game-Changer for Ulcerative Colitis Treatment

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a clinical study titled ‘A ...
Hospital Healthcare Europe6d

Early response predicts long-term biologic success in psoriasis, study finds

Patients with psoriasis who show an early response to the biologics risankizumab or guselkumab are more likely to have a long ...